Navigation Links
Pathway for Biosimilars Act Protects Patients, Promotes Competition, Preserves Innovation and Creates Quality Jobs, Lilly Says
Date:3/17/2009

INDIANAPOLIS, March 17 /PRNewswire-FirstCall/ -- Today Eli Lilly and Company (NYSE: LLY) announced its support for the Pathway for Biosimilars Act. The U.S. has a 25-year history of success with laws promoting the discovery of new, chemical-based medicines and providing an abbreviated approval process under which generic versions of those new medicines can to come to market. But Congress has yet to take that step with the most advanced new medicines, called biological drugs or simply "biologics."

Lilly said the Pathway for Biosimilars Act, reintroduced in the 111th Congress by Reps. Anna Eshoo (D-Calif.), Jay Inslee (D-Wash.) and Joe Barton (R-Texas), would successfully create a pathway that carefully weighs the needs of patients and stakeholder companies. This balance, Lilly said, would assure patients and payers the benefits that come from greater competition, preserve incentives for biotechnology innovation and foster investments that will produce more high-paying jobs in the life sciences.

"Lilly commends Representatives Eshoo, Inslee and Barton for joining together and introducing a carefully considered, balanced approach to ensuring the promise of biotech medicine becomes a reality for patients," said Robert Armitage, Lilly's senior vice president and general counsel. "Making biotech discoveries entails many years of research, massive investments and high risk. This bill makes certain that innovator companies can continue to make these types of investments in new therapies for patients, and that, once a reasonable period of time has passed for recouping its investment, generic companies can copy those innovations in a safe, scientifically sound manner."

The key provision of the Eshoo-Inslee-Barton bill striking this balance is the 14-year "data protection period." The legislation's formula would offer al
'/>"/>

SOURCE Eli Lilly and Company
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Biogenerics Legislation Provides Critical Pathway to Affordable Access for Patients with Chronic and Complex Conditions
2. Bavarian Nordic Has Essentially Agreed a Pathway for the Licensure of IMVAMUNE(R) With the FDA After Successful End of Phase II Meeting
3. Millipore Launches an Interactive Biological Pathway Tool Using GeneGos Manually Curated Pathway Maps
4. Cardiovascular Side Effects of Pioglitazone and Rosiglitazone Linked to Vascular and Energy Pathways by Genomas Clinical Study
5. GEN Reports Growing Focus on PI3-Kinase Pathway in Cancer Research
6. Debiopharm and Aurigene Sign Licensing Agreement for the Development and Commercialisation of Debio 0617, a Novel Inhibitor of an Undisclosed Oncology Pathway
7. Frost & Sullivan Awards Genpathway 2008 Healthcare Innovation Award
8. Trillium secures additional financing on the strength of lead program and proprietary position around the CD200 immunoregulatory pathway
9. Pathway Diagnostics Announces Commercial Availability of Second Generation SensiTrop(TM) II Molecular HIV Co-receptor Tropism Assay
10. Study Suggests GAMMAGARD LIQUID May Target the Primary Pathway Involved in Alzheimers Disease
11. Ingenuity Systems and Pfizer Announce Strategic Partnership for Pathway Analysis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/15/2014)... (PRWEB) November 14, 2014 As ... is making significant investments in its network and ... modern cold chain and the complex requirements of ... ongoing focus on customized logistics and transportation, and ... of existing facilities. There will be an emphasis ...
(Date:11/15/2014)... (PRWEB) November 14, 2014 The ... Anesthesia, Surgical, Performance), by Application (Perioperative, Preoperative, operating ... Mode (Web-Based, On-Premise) - Global Forecast to 2019.” ... with an analysis and forecast of value by ... performance. Along with this, the value and volumes ...
(Date:11/15/2014)... DUBLIN , November 14, 2014 /PRNewswire/ ... ) has announced the addition of the  ... Consumables & Services, Application, & by End ... to their offering.  ,     (Logo: http://photos.prnewswire.com/prnh/20130307/600769) , ... was valued at $1,569.00 million in 2014, ...
(Date:11/12/2014)... -- ReachBio Research Labs (a registered trade name of ReachBio ... that it has signed an agreement with Funakoshi Co., ... non-exclusive distribution rights to ReachBio,s human primary cell product ... Japan . Under a companion agreement, Funakoshi ... Japanese drug development companies. Photo - ...
Breaking Biology Technology:QuickSTAT Announces Global Expansion Plan to Enhance Its Global Network and Cold Chain Logistics Capabilities for Life Sciences 2Operating Room Management Market Worth $4,551.1 Million by 2019 - New Report by MarketsandMarkets 2Operating Room Management Market Worth $4,551.1 Million by 2019 - New Report by MarketsandMarkets 3Operating Room Management Market Worth $4,551.1 Million by 2019 - New Report by MarketsandMarkets 4Global Protein Characterization and Identification (Chromatography, Electrophoresis, Mass Spectroscopy) Market - Forecast to 2019 2Global Protein Characterization and Identification (Chromatography, Electrophoresis, Mass Spectroscopy) Market - Forecast to 2019 3Funakoshi to Distribute ReachBio Research Labs Human Primary Cell Products in Japan 2Funakoshi to Distribute ReachBio Research Labs Human Primary Cell Products in Japan 3
... ... expanding its Research Triangle Operations. Scott Garrison is named a new partner. ... Research Triangle Park, ... and leading provider of outsourced CFO-level financial and management services for technology and biotechnology ...
... ... Improve Precision and Reduce Risk of False Positives/Negatives , ... Rochester, New York (PRWEB) January 8, 2010 -- ... announced today that a leading global CRO has selected iCardiac as a preferred vendor ...
... , , , , ... China,Yongxin Pharmaceuticals, Inc. (OTC Bulletin Board: CYXN; "China Yongxin,Pharmaceuticals" ... of Chinese traditional medicines, pharmaceutical products, natural,health products, health ... Company today announced that it had opened three new ...
Cached Biology Technology:TechCFO Continues Research Triangle Park Expansion; Garrison Named New Partner 2Leading Global CRO Selects iCardiac as Preferred Vendor 2China Yongxin Pharmaceuticals Opened Three New Stores in 2009 and Expanded Customer Base 2China Yongxin Pharmaceuticals Opened Three New Stores in 2009 and Expanded Customer Base 3
(Date:11/3/2014)... study published in this month,s Proceedings of ... of a recently discovered communication molecule of the body,s ... known to limit inflammation and the current study reports ... the ability of the immune system to recognize and ... IL-37,s effect on the immune system now allows us ...
(Date:11/2/2014)... (2 November 2014)—In support of a bold quest to ... Melinda Gates Foundation today announced an award of US$156 ... Initiative (MVI) in building new vaccines that will interrupt ... the "accelerating to zero" agenda. Such vaccines would ensure ... be called an "immunological bed net." , This ...
(Date:10/31/2014)... 1900s, Brazil was the world,s largest producer of cocoa. ... a 800, 000 ha region of rainforest in the ... shade trees. Whereas the surrounding rainforest was a biodiversity ... a handful of seeds introduced in the mid 1700s, ... Brazilian scientist Gonçalo Pereira, "This scenario created a very ...
Breaking Biology News(10 mins):PNAS: From HIV to cancer, IL-37 regulates immune system 2New malaria vaccines to prevent infection and block transmission get a shot in the arm 2New malaria vaccines to prevent infection and block transmission get a shot in the arm 3New malaria vaccines to prevent infection and block transmission get a shot in the arm 4Scientists seek cure for devastating witches' broom disease of the chocolate tree 2Scientists seek cure for devastating witches' broom disease of the chocolate tree 3
... not only uncomfortable, it can be deadlycausing proteins to ... scientists have understood the molecular mechanisms that enable animals ... that directly trigger heat sensor proteins known as TRP ... animals sense very small temperature differences in the comfortable ...
... and induced pluripotent stem cell technology are among ... through The Michael J. Fox Foundation,s Rapid Response ... to drive transformative treatments and a cure for ... 15 high-risk, high-reward Parkinson,s disease research projects under ...
... atmosphere, and from the human use of fossil fuels, the ... life support system. The chemical balance of the sea has ... pH of the sea,s surface water has gone down by ... just over a century ago. Jon Havenhand and Michael Thorndyke, ...
Cached Biology News:Summer heat too hot for you? What is comfortable? 2Summer heat too hot for you? What is comfortable? 3Michael J. Fox Foundation Funds $1.1 Million for Cutting-edge Approaches to Parkinson's Disease 2Michael J. Fox Foundation Funds $1.1 Million for Cutting-edge Approaches to Parkinson's Disease 3Acidification of the sea hampers reproduction of marine species 2
... ST-190-XY is an automated instrument with ... cells in real-time using light or fluorescence ... endothelial, muscle, and fibroblast cells can be ... the X and Y axis of our ...
... Smart Solutions has now entered the next ... by partnering up with Cellomics, Inc. The ... integration of Beckman Coulter‘s automated solutions systems ... biological information at the sub-cellular level. The ...
... biologic production demands on cell and tissue ... cell populations. Therefore, both cell concentration and ... accurately and precisely. The new Vi-CELLTM Cell ... effective means to perform the trypan blue ...
... powerful yet simple technology for labeling peptides, ... provides the heterobifunctional linkers SFB and SANH ... It enables conjugation of various tags including ... a variety of proteins. , ...
Biology Products: